Lung Ultrasound for Assessment of Patients With Moderate to Severe Covid-19

Corona Virus Infection Clinical Trial

Official title: Lung Ultrasound for Assessment of Patients With Moderate to Severe Covid-19

Status Completed

Clinical Trial Summary

This observational study will describe lung ultrasound (LUS) findings over time in hospitalized patients with moderate to severe Covid-19 lung disease. Our primary aim is to investigate if lung ultrasound can identify and/or predict patients requiring mechanical ventilation. Another aim is to describe LUS findings associated with clinical findings and patient condition.

Clinical Trial Description

Study patients with moderate to severe Covid-19 infection will be screened with lung ultrasound daily. Lung ultrasound will be assessed by LUS-score for acute respiratory distress syndrome (ARDS) (0-36 points, Bouhemad 2015). Findings of B-line artifacts and consolidations will be noted. In addition to LUS, clinical parameters from physical examination and laboratory tests will be collected. Participants wil be followed until either admission to intensive care unit (ICU) for mechanical ventilation or until clinical improvement. A group of patients with mild Covid-19 infection will be recruited and screened once as reference.

Apart from assessment with LUS, patients are managed according to routine care. ;

Related Conditions & MeSH terms

• Communicable Diseases
• Corona Virus Infection
• Coronaviridae Infections
• Coronavirus Infections
• Infection
• Virus Diseases

• NCT number: NCT04412551
• Study type: Observational [Patient Registry]
• Source: Dalarna County Council, Sweden
• Status: Completed
• Start date: May 20, 2020
• Completion date: December 31, 2020